The incidence and epidemiology of β-lactam resistance in Haemophilus influenzae

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 4, 1996, Pages 737-746

  James, P A ^a,c   Lewis, D A ^a,d   Jordens, J Z ^b   Cribb, J ^a   Dawson, S J ^a   Murray, S A ^a  

^a ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ROYAL GWENT HOSPITAL   (United Kingdom)

^d Hlth Commn for Wiltshire and Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; OUTER MEMBRANE PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; EYE INFECTION; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY TRACT INFECTION; RIBOTYPING; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; AGED; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CHILD; DRUG RESISTANCE, MICROBIAL; FEMALE; GREAT BRITAIN; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 0029961599     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.4.737     Document Type: Article

References (19)

1. Anderson, J. R., Smith, M. D., Kibbler, C. C., Holton, J. & Scott, G. M. (1994). A nosocomial outbreak due to non-encapsulated Haemophilus influenzae: analysis of plasmids coding for antibiotic resistance. Journal of Hospital Infection 27, 17-27.
2. Brown, N. M., Bedford, K. A., Holt, H. A., McCulloch, S. Y., MacGowan, A. P. & Reeves, D. S. (1992). Cefuroxime resistance in Haemophilus influenzae. Lancet 340, 552.
3. Heelan, J. S., Chesney, D. & Guadagno, G. (1992). Investigations of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines. Journal of Clinical Microbiology 30, 1674-7.
4. James, P. A., Hossain, F. K., Lewis, D. A. & White, D. G. (1993). β-Lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime. Journal of Antimicrobial Chemotherapy 32, 239-46.
5. Jordens, J. Z., Leaves, N. I., Anderson, E. C. & Slack, M. P. E. (1993). Polymerase chain reaction-based stain characterization of non-capsulate Haemophilus influenzae. Journal of Clinical Microbiology 31, 2981-7.
6. Kilian, M. (1976). A taxonomic study of the genus Haemophilus, with the proposal of a new species. Journal of General Microbiology 93, 9-62.
7. Mendelman, P. M., Chaffin, D. O., Clausen, C., Stull, T. L., Needham, C., Williams, J. D. et al. (1986). Failure to detect ampicillin-resistant, non-β-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrobial Agents and Chemotherapy 30, 274-80.
8. Mortensen, J. E., LaRocco, M., Himes, S. L., Inderlied, C., Daly, J. A., Campos, J. M. et al. (1990). Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam. Diagnostic Microbiology and Infectious Disease 13, 345-8.
9. O'Callaghan, C. H., Morris, A., Kirby, S. M. & Shingler, A. H. (1972). Novel method for the detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-8.
10. Paton, J. H., Holt, H. A. & Bywater, M. J. (1990). Measurement of MICs of antibacterial agents by spiral gradient endpoint compared with conventional dilution method. International Journal of Experimental and Clinical Chemotherapy 3, 31-8.
11. Patterson, J. E., Madden, G. M., Krisiunus, E. P., Masecar, B., Hierholzer, W. J., Zervos, M. J. et al. (1988). A nosocomial outbreak of ampicillin-resistant Haemophilus influenzae type b in a geriatric unit. Journal of Infectious Diseases 157, 1002-7.
12. Powell, M., Fah, Y. S., Seymour, A., Yuan, M. & Williams, J. D. (1992). Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. Journal of Antimicrobial Chemotherapy 29, 547-54.
13. Powell, M. & Livermore, D. M. (1990). Selection and transformation of non-β-lactamase-mediated insusceptibility to β-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agents. Journal of Antimicrobial Chemotherapy 26, 741-7.
14. Powell, M. & Williams, J. D. (1988). Detection of ampicillin resistant Haemophilus influenzae in United Kingdom laboratories. Journal of Clinical Pathology 41, 716-9.
15. Reeves, D. S., Bywater, M. J. & Holt, H. A. (1993). The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected in 20 centres. Journal of Antimicrobial Chemotherapy 31, 345-62.
16. Schalkowsky, S. (1991). Measures of susceptibility from a spiral gradient of drug concentrations. In Antimicrobial Susceptibility Testing: Critical Issues of the 90's. (Poupard J. A., Walsh. L. R. & Kleger, B., Eds), pp. 107-20. Plenum Press, New York.
17. Sturm, A. W., Mostert, R., Rouing, P. J. E., van Klingeren, B. & van Alphen, L. (1990). Outbreak of multiresistant non-encapsulated Haemophilus influenzae infections in a pulmonary rehabilitation centre. Lancet 335, 214-6.
18. Valentini, S., Coratza, G., Rossolini, G. M., Massidda, O. & Satta, G. (1994). In-vitro evaluation of cefpodoxime. Journal of Antimicrobial Chemotherapy 33, 495-508.
19. Wise, R., Andrews, J. M., Ashby, J. P. & Thornber, D. (1990). The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins. Journal of Antimicrobial Chemotherapy 25, 541-50.